Be Familiar With Tenecteplase for Acute Ischemic Stroke

You’ll hear buzz about the thrombolytic tenecteplase (TNKase) now that it’s approved by Health Canada for treating acute ischemic stroke.

This adds to the uses for tenecteplase, since it’s already approved for patients with a heart attack caused by an occlusive clot.

Tenecteplase is a modified version of alteplase...made by altering 3 sites on the tPA enzyme giving it a longer half-life and more specificity.